FDA Inspection
Livzon New North River Pharmaceutical Co., Ltd.Livzon New North River Pharmaceutical Co., Ltd. – FDA Inspection, Dec 20, 2024
Record Details
This FDA Inspection record concerns Livzon New North River Pharmaceutical Co., Ltd., with an inspection on December 20, 2024, issued by the Office of Inspections and Investigations, covering human drugs.
- Inspection Date
- December 20, 2024
- Product Type
- Human Drugs
View Company Profile
ID · 74bc05d7-54dd-4d79-92ba-87de6e4cada4
Inspection Facts
- Inspection number
- 1260618
- FDA center
- Human Drugs
Other FDA inspections of Livzon New North River Pharmaceutical Co., Ltd.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| May 23, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 6, 2015 | NAI | Center for Veterinary Medicine | Pre-Approval Eval. of Animal Drugs and Food Additives |
| March 22, 2013 | NAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
| July 16, 2009 | OAI | Center for Veterinary Medicine | Pre-Approval Eval. of Animal Drugs and Food Additives |
Other documents for Livzon New North River Pharmaceutical Co., Ltd.
- FDA Inspection 1095580 - 2019-05-23
- FDA Inspection 951219 - 2015-11-06
- FDA Inspection 824387 - 2013-03-22
- FDA Inspection 604389 - 2009-07-16
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.